You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abivertinib

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

Recruiting
  • Prostate Cancer
  • Prostate Cancer Metastatic
  • La Jolla, California
  • +1 more
Feb 2, 2023

Covid19 Trial in Santo André (STI-5656, Placebo)

Completed
  • Covid19
  • Santo André, SP, Brazil
    Hospital e Maternidade Christovão da Gama
Nov 1, 2021

Covid-19 Trial in United States (Abivertinib, Standard of Care)

Completed
  • Covid-19
  • Abivertinib
  • Standard of Care
  • Washington, District of Columbia
  • +5 more
Nov 1, 2021

Advanced NSCLC Trial in Guangzhou (Abivertinib Maleate Capsules, Placebo Gefitinib Tablets, Gefitinib Tablets)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer
  • Abivertinib Maleate Capsules
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provicial People's Hospital
Feb 25, 2019

Metastatic NSCLC Trial in China (AC0010)

Active, not recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Beijing, Beijing, China
  • +16 more
Sep 2, 2021

Non Small Cell Lung Cancer Trial in France, Spain, United States (AC0010MA)

Terminated
  • Non Small Cell Lung Cancer
  • Duarte, California
  • +7 more
Oct 28, 2019

Carcinoma,Non-Small-Cell Lung Trial in Nanjing (AC0010)

Completed
  • Carcinoma，Non-Small-Cell Lung
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Jan 31, 2019

B-cell Lymphoma Trial in Beijing, Hangzhou (AC0010MA)

Unknown status
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Jan 31, 2019

NSCLC Trial in China (Pemetrexed, Cisplatin 75mg/m2, AC0010)

Withdrawn
  • NSCLC
  • Beijing, Beijing, China
  • +20 more
Jan 31, 2019

Metastatic NSCLC Trial in China (AC0010)

Unknown status
  • Metastatic Non-small Cell Lung Cancer
  • Beijing, Beijing, China
  • +24 more
Feb 18, 2019

NSCLC Trial in Nanjing (AC0010)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Sep 29, 2017

NSCLC Trial in Guangzhou (AC0010)

Unknown status
  • Non-Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 21, 2016